From: Cost-effectiveness of stimulation of the sphenopalatine ganglion (SPG) for the treatment of chronic cluster headache: a model-based analysis based on the Pathway CH-1 study
Variable
Pathway CH-1 (N = 28)
Age (years)
45 (20–63)
Male gender (no.; %)
27 (84 %)
Baseline CH attacks per day
2.74 (0.57–10)